Tandem Diabetes Care (NSDQ:TNDM) today announced the pricing details of a $22.5 million underwritten public offering. The company priced 18 million shares of its common stock at $1.25 apiece.
Tandem also gave underwriters a 30-day option to buy up to an additional 2.7 million shares of common stock at the public offering price. The offering is expected to close on March 28.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem Diabetes Care prices $22.5m public offering appeared first on MassDevice.